lycorine has been researched along with Benign Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andolfi, A; Evdokimov, NM; Evidente, A; Frolova, LV; Kiss, R; Kornienko, A; Lamoral-Theys, D; Magedov, IV; Mathieu, V; Pelly, SC; van Otterlo, WA | 1 |
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Li, X; Lv, F; Wang, Y | 1 |
| Deng, X; Hu, H; Liang, Z; Liu, W; Shao, Z; Song, Q; Wang, B; Wang, S; Xing, X; Yang, W; Zhang, Y; Zhong, B; Zhou, Z; Zhu, J | 1 |
| Decaestecker, C; Dubois, J; Evidente, A; Kiss, R; Kornienko, A; Lamoral-Theys, D; Mathieu, V; Pottier, L | 1 |
| Gong, T; Guo, Y; Liu, X; Sun, X; Zhang, Q; Zhang, Z | 1 |
2 review(s) available for lycorine and Benign Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Lycorine and its derivatives for anticancer drug design.
Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Drug Design; Humans; Neoplasms; Phenanthridines; Structure-Activity Relationship | 2010 |
4 other study(ies) available for lycorine and Benign Neoplasms
| Article | Year |
|---|---|
In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivatives.
Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Neoplasms; Phenanthridines; Structure-Activity Relationship | 2011 |
Lycorine inhibits angiogenesis by docking to PDGFRα.
Topics: Amaryllidaceae Alkaloids; Angiogenesis Inhibitors; Cell Proliferation; Human Umbilical Vein Endothelial Cells; Humans; Molecular Docking Simulation; Neoplasms; Neovascularization, Pathologic; Phenanthridines; Receptor, Platelet-Derived Growth Factor alpha; Sunitinib | 2022 |
Amplification of oxidative stress with lycorine and gold-based nanocomposites for synergistic cascade cancer therapy.
Topics: Amaryllidaceae Alkaloids; Animals; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum Stress; Folic Acid; Gold; Humans; Mice; Microscopy, Fluorescence; Mitochondria; Nanocomposites; Neoplasms; Osteosarcoma; Oxidative Stress; Phenanthridines; Reactive Oxygen Species; Silicon Dioxide | 2021 |
Mannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific delivery.
Topics: Amaryllidaceae Alkaloids; Animals; Cell Proliferation; Chemistry, Pharmaceutical; CHO Cells; Cricetinae; Cricetulus; Drug Delivery Systems; Emulsions; Inhibitory Concentration 50; Intracellular Space; Ions; Mannose; Microscopy, Confocal; Nanoparticles; Neoplasms; Oleic Acid; Particle Size; Phenanthridines; Solubility; Static Electricity | 2012 |